AlphaStocks
1.7
Avoid

Phibro Animal Health Corp (PAHC)

As of Sep 20, 2026, Phibro Animal Health Corp (PAHC) scores 1.7/10 on AlphaStocks' five-model composite, #165 of 168 Health Care stocks. At $35, PAHC trades 31% above its model fair value of $26.

Health Care / Pharmaceuticals

S&P SmallCap 600

$34.62

Scores poorly across most models. Proceed with caution.

Avoid

Score based on 4 of 5 models — moderate confidence

Data as of Sep 20, 2026

#165out of 168 in Health Care

Is PHIBRO ANIMAL HEALTH CORP a Good Investment in 2026?

PHIBRO ANIMAL HEALTH CORP (PAHC) scores 1.7 out of 10 on AlphaStocks' composite model, earning a Avoid rating. The Piotroski model rates PHIBRO ANIMAL HEALTH CORP as Attractive (6/9). However, the Lynch model rates it Caution. PHIBRO ANIMAL HEALTH CORP currently trades 31% above its estimated fair value of $26. PHIBRO ANIMAL HEALTH CORP ranks #165 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E29.2ROE17.5Market Cap1BDiv Yield1.5

Estimated Fair Value

$26.4731% above

Trading above estimated fair value. Rapid eps growth (1890%) partially justifies the premium.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

6/9

Buffett

Caution

Business quality & competitive moat

Graham

Neutral

Significantly above fair value

Lynch

Caution

Growth rate vs price (PEG)

Greenblatt

Neutral

Earnings yield 3.5% · ROC 9%

Frequently Asked Questions

Is PHIBRO ANIMAL HEALTH CORP (PAHC) a good investment?
As of Sep 20, 2026, Phibro Animal Health Corp (PAHC) scores 1.7/10 on AlphaStocks' five-model composite, #165 of 168 Health Care stocks. At $35, PAHC trades 31% above its model fair value of $26. That score is below average, suggesting caution.
What is PHIBRO ANIMAL HEALTH CORP's Piotroski F-Score?
PHIBRO ANIMAL HEALTH CORP's Piotroski F-Score status is Attractive. The raw score is 6/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is PAHC overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $26, PAHC appears overvalued. The stock currently trades 31% above its estimated fair value. Trading above estimated fair value. Rapid eps growth (1890%) partially justifies the premium.
How does PAHC compare to other Health Care stocks?
PHIBRO ANIMAL HEALTH CORP ranks #165 out of 168 stocks in the Health Care sector, placing it in the top 98% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about PAHC?
AlphaStocks evaluates PAHC using five proven investment models. Piotroski: Attractive; Buffett: Caution; Graham: Neutral; Lynch: Caution; Greenblatt Magic Formula: Neutral. These models are combined into a single composite score of 1.7/10.

Similar Stocks

AMPHLLYACAD

Compare PAHC with

AMPH vs PAHCLLY vs PAHCACAD vs PAHC

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer